New indication of human interleukin-2 and antituberculotic combination medicine


Application Number: 00109365
Application Date: 2000.06.02
Publication Number: 1326783
Publication Date: 2001.12.19
Priority Information:
International: A61K38/20;A61P31/06
Applicant(s) Name: Hou Yunde
Address:
Inventor(s) Name: Hou Yunde;Zhang Lilan
Patent Agency Code: 00000
Patent Agent:
Abstract The combination of natural human interleukin-2 (IL-2) and antituderculotic is used to treat tuberculosis patient in low immunity state, and this can result in curative effect similar to or even higher than that of large dose antituberculotic.